IRIS
FRUMENTO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 429
Totale 429
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 429
Totale 429
Salva come PNG Salva come JPEG
Città #
Genova 171
Genoa 145
Rapallo 108
Bordighera 5
Totale 429
Salva come PNG Salva come JPEG
Nome #
A2A-D2 heteromers on striatal astrocytes: Biochemical and biophysical evidence 151
Acute stress induces short- and long-lasting modifications of glutamate transmission in the prefrontal cortex at pre- and peri-synaptic compartments 65
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 42
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 41
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 40
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 40
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 39
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity 8
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex. 7
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 6
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation 5
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis 5
Effects of the in-vivo treatment with the non-selective GPR17 antagonist montelukast on disease outcome in the SOD1G93A mouse model of ALS 4
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 2
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 2
null 1
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 1
Totale 459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.149
article - articoli 1.389
book - libri 0
conference - conferenze 493
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 10 3 0 4 6 8 9 6 4 6 2 2
2020/202135 1 2 0 2 0 0 0 2 1 21 3 3
2021/202288 3 2 7 0 4 1 11 26 7 9 7 11
2022/2023131 12 12 4 15 14 20 0 4 26 8 15 1
2023/2024130 3 7 7 10 18 41 14 6 4 3 9 8
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 459